Who invested in Pelage Pharmaceuticals?
Pelage Pharmaceuticals's investors include Google Ventures and ARCH Venture Partners.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$120Mraised across 1 round since 2025, from 1 source
Source recordedSEC filing: $120M sold, first sale Sept 2025
Pelage Pharmaceuticals's investors include Google Ventures and ARCH Venture Partners.
Pelage Pharmaceuticals has raised $120M across 1 round since 2025.
Pelage Pharmaceuticals's most recent round was a Series B of $120M in Oct 2025.
Its most recent round, $120M in Oct 2025, is also its largest on record.
Pelage Pharmaceuticals's first round on record, in Oct 2025, was backed by Google Ventures and ARCH Venture Partners.
Pelage Pharmaceuticals's latest named round is a Series B, in Oct 2025.
Pelage Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.